Assignee
NEXYS THERAPEUTICS INC
US·3 granted patents·2 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
5 records- 0179US12168646B2Aryl hydrocarbon receptor agonists and uses thereofNEXYS THERAPEUTICS INC·Filed 2024·Granted Dec 17, 2024·0 cites·21 claims
- 0278US12371408B2Aryl hydrocarbon receptor agonists and uses thereofNEXYS THERAPEUTICS INC·Filed 2024·Granted Jul 29, 2025·0 cites·20 claims
- 0374US2026022099A1Aryl hydrocarbon receptor agonists and uses thereofNEXYS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0469US2024398776A1Inhibitors of tgf-beta r1 (alk5) useful to treat cell proliferation disordersNEXYS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0552US12102626B2(Pyridin-2-yl)amine derivatives as TGF-BETA R1 (ALK5) inhibitors for the treatment of cancerNEXYS THERAPEUTICS INC·Filed 2019·Granted Oct 1, 2024·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when NEXYS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →